Direct Quantitation of Psilocybin and Psilocin by One-Dimensional 1H and 31P qNMR in a revived Greek specimen of Psilocybe cyanescens
Planta Medica December 1, 2022 Prokopios Magiatis, Evangelos Dadiotis, Romanos Konstantinos Antonopoulos et al. 1 citation
The genus Psilocybe contains over two hundred species of mushroom-forming fungi that produce the secondary metabolite psilocybin, which is a prodrug converted in the body to the active metabolite psilocin. Psilocybin is currently being used in clinical trials for treating Major Depressive Disorder, existential distress in terminally ill patients, and Alcohol Use Disorder, creating a need to investigate and quantitate these substances.